AtaiBeckley (ATAI) Assets Average (2021 - 2026)
AtaiBeckley (ATAI) posted quarterly Assets Average of $278.8 million for Q1 2026.
AtaiBeckley (ATAI) Assets Average (2021 - 2026) Analysis & Trends
AtaiBeckley's Assets Average history runs 1 years deep, the most recent figure standing at $278.8 million for Q1 2026.
- Quarterly Assets Average fell 71.08% year-over-year to $81.3 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $81.3 million (down 71.08% YoY) and the FY2024 annual result came in at $226.4 million, down 24.39% from the prior year.
- Assets Average fell to $81.3 million in Q1 2025 per ATAI's latest filing, from $242.4 million in the prior quarter.
- Over five years, Assets Average peaked at $324.0 million in Q4 2022 and troughed at $885000.0 in Q2 2021.
- A 5-year average of $173.5 million and a median of $254.8 million in 2023 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2025: Assets Average surged 11377.83% in 2022, then slumped 71.08% in 2025.
- Over 5 years, Assets Average stood at $2.8 million in 2021, then soared by 11377.83% to $324.0 million in 2022, then retreated by 7.15% to $300.8 million in 2023, then retreated by 19.41% to $242.4 million in 2024, then sank by 66.45% to $81.3 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $81.3 million, $242.4 million, and $281.3 million for Q1 2025, Q2 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | AtaiBeckley | 2.69 Bn | 2.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 264.84 Mn |
| Mar 31, 2026 | 278.80 Mn |
| Mar 31, 2025 | 81.34 Mn |
| Jun 30, 2024 | 242.45 Mn |
| Mar 31, 2024 | 281.30 Mn |
| Dec 31, 2023 | 300.85 Mn |
| Sep 30, 2023 | 280.91 Mn |
| Jun 30, 2023 | 267.16 Mn |
| Mar 31, 2023 | 293.08 Mn |
| Dec 31, 2022 | 324.02 Mn |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 885,000.00 |
| Jun 30, 2021 | 885,000.00 |
| Mar 31, 2021 | 6.60 Mn |